Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04713553
Brief Title: A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 Against COVID-19 in Healthy Participants

First Submitted : January 15, 2021
First Submitted that Met QC Criteria : January 15, 2021
First Posted : January 19, 2021

Last Update Submitted that Met QC Criteria : March 23, 2021
Last Update Posted : March 24, 2021